J.A. Tweed

644 total citations
22 papers, 452 citations indexed

About

J.A. Tweed is a scholar working on Psychiatry and Mental health, Pharmacology and Epidemiology. According to data from OpenAlex, J.A. Tweed has authored 22 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Psychiatry and Mental health, 5 papers in Pharmacology and 3 papers in Epidemiology. Recurrent topics in J.A. Tweed's work include Schizophrenia research and treatment (8 papers), Treatment of Major Depression (5 papers) and Electroconvulsive Therapy Studies (4 papers). J.A. Tweed is often cited by papers focused on Schizophrenia research and treatment (8 papers), Treatment of Major Depression (5 papers) and Electroconvulsive Therapy Studies (4 papers). J.A. Tweed collaborates with scholars based in United Kingdom, Brazil and Spain. J.A. Tweed's co-authors include J. Raniwalla, Mariona Pinart, Mónica Rengifo‐Pardo, Antonio Macaya, Jorge Alvar, Urbà González, Stephen Cooper, Sonia Dollfus, M. Petit and William Perkins and has published in prestigious journals such as Biological Psychiatry, Cochrane Database of Systematic Reviews and Psychopharmacology.

In The Last Decade

J.A. Tweed

19 papers receiving 434 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.A. Tweed United Kingdom 8 190 179 146 70 49 22 452
Júlio Casoy Brazil 15 105 0.6× 147 0.8× 63 0.4× 63 0.9× 48 1.0× 26 703
Pavel Kramata United States 12 24 0.1× 170 0.9× 111 0.8× 28 0.4× 39 0.8× 17 598
Eduardo A Leiderman Argentina 10 25 0.1× 65 0.4× 162 1.1× 34 0.5× 13 0.3× 39 487
Thomas Reed United States 14 17 0.1× 83 0.5× 64 0.4× 39 0.6× 18 0.4× 18 587
Monica McCusker United Kingdom 11 19 0.1× 67 0.4× 76 0.5× 13 0.2× 32 0.7× 14 557
Somnath Mondal India 10 22 0.1× 49 0.3× 76 0.5× 43 0.6× 2 0.0× 36 335
Jerry L. Lewis United States 6 12 0.1× 169 0.9× 196 1.3× 85 1.2× 5 0.1× 8 394
Sandy McBride United Kingdom 15 63 0.3× 104 0.6× 77 0.5× 20 0.3× 9 0.2× 24 531
S. D. Soni United Kingdom 10 21 0.1× 202 1.1× 15 0.1× 41 0.6× 38 0.8× 29 356
Ann E. Bowler United States 8 87 0.5× 97 0.5× 42 0.3× 6 0.1× 34 0.7× 14 403

Countries citing papers authored by J.A. Tweed

Since Specialization
Citations

This map shows the geographic impact of J.A. Tweed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.A. Tweed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.A. Tweed more than expected).

Fields of papers citing papers by J.A. Tweed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.A. Tweed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.A. Tweed. The network helps show where J.A. Tweed may publish in the future.

Co-authorship network of co-authors of J.A. Tweed

This figure shows the co-authorship network connecting the top 25 collaborators of J.A. Tweed. A scholar is included among the top collaborators of J.A. Tweed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.A. Tweed. J.A. Tweed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tweed, J.A., et al.. (2024). Migration in psychiatry trainees in the United Kingdom: results from a cross-sectional survey. International Journal of Mental Health. 54(1). 102–112. 1 indexed citations
2.
3.
Tweed, J.A., et al.. (2021). Patient adherence with infection control measures on a novel ‘COVID-19 triage’ psychiatric in-patient ward. BJPsych Open. 7(4). e131–e131. 6 indexed citations
4.
Pinart, Mariona, José-Ramón Rueda, Gustavo Adolfo Sierra Romero, et al.. (2020). Interventions for American cutaneous and mucocutaneous leishmaniasis. Cochrane Database of Systematic Reviews. 2020(8). 47 indexed citations
5.
Silva, Valter, et al.. (2019). Complementary therapies for chronic plaque psoriasis. Cochrane Database of Systematic Reviews. 1 indexed citations
6.
Silva, Valter, et al.. (2014). Complementary therapies for chronic plaque psoriasis. Cochrane Database of Systematic Reviews.
7.
Lansbury, Louise, Jo Leonardi‐Bee, William Perkins, et al.. (2010). Interventions for non-metastatic squamous cell carcinoma of the skin. Cochrane Database of Systematic Reviews. 2015(3). CD007869–CD007869. 57 indexed citations
8.
González, Urbà, Mariona Pinart, Mónica Rengifo‐Pardo, et al.. (2009). Interventions for American cutaneous and mucocutaneous leishmaniasis. Cochrane Database of Systematic Reviews. 8(2). CD004834–CD004834. 153 indexed citations
9.
Cooper, Stephen, et al.. (2000). Zotepine in the prevention of recurrence: a randomised, double-blind, placebo-controlled study for chronic schizophrenia. Psychopharmacology. 150(3). 237–243. 45 indexed citations
10.
Tweed, J.A., et al.. (2000). The safety and efficacy of zotepine in the treatment of schizophrenia: Results of a one-year naturalistic clinical trial. International Journal of Psychiatry in Clinical Practice. 4(4). 299–306. 8 indexed citations
11.
Cooper, S.J., et al.. (2000). Zotepine is effective in preventing recurrence in patients with chronic schizophrenia. Schizophrenia Research. 41(1). 207–208. 7 indexed citations
12.
Cooper, Stephen, et al.. (2000). A placebo‐controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia. Acta Psychiatrica Scandinavica. 101(3). 218–225. 48 indexed citations
13.
Cooper, S.J., et al.. (1998). Zotepine is effective in preventing recurrence in patients with chronic schizophrenia. European Neuropsychopharmacology. 8. S232–S232. 4 indexed citations
14.
Appleby, P N, et al.. (1998). Efficacy of zotepine in schizophrenia — A global meta-analysis. European Neuropsychopharmacology. 8. S215–S215. 1 indexed citations
15.
Appleby, P N, et al.. (1998). A comparison of newer vs traditional antipsychotics and placebo using meta-analysis techniques. European Neuropsychopharmacology. 8. S214–S215. 2 indexed citations
16.
Cooper, S.J., et al.. (1997). Zotepine in the prevention of relapse. Biological Psychiatry. 42(1). 41S–41S. 6 indexed citations
17.
Cooper, S.J., et al.. (1997). P.2.105 Zotepine in the treatment of chronic schizophrenia. European Neuropsychopharmacology. 7. S225–S225. 1 indexed citations
18.
Tweed, J.A., et al.. (1997). A Multicentre Naturalistic Long Term Study of Zotepine. European Psychiatry. 12(S2). 214s–214s. 1 indexed citations
19.
Petit, M., J. Raniwalla, J.A. Tweed, et al.. (1996). A comparison of an atypical and typical antipsychotic, zotepine versus haloperidol in patients with acute exacerbation of schizophrenia: a parallel-group double-blind trial.. PubMed. 32(1). 81–7. 60 indexed citations
20.
Petit, M.-A., J. Raniwalla, E. Leutenegger, J.A. Tweed, & Francine L. Kelly. (1995). P-4-20 Double-blind study of zotepine vs haloperidol in schizophrenia. European Neuropsychopharmacology. 5(3). 333–333. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Júlio Casoy Breakdown of academic impact, for papers by Pavel Kramata Breakdown of academic impact, for papers by Eduardo A Leiderman Breakdown of academic impact, for papers by Thomas Reed Breakdown of academic impact, for papers by Monica McCusker Breakdown of academic impact, for papers by Somnath Mondal Breakdown of academic impact, for papers by Jerry L. Lewis Breakdown of academic impact, for papers by Sandy McBride Breakdown of academic impact, for papers by S. D. Soni Breakdown of academic impact, for papers by Ann E. Bowler
Rankless by CCL
2026